PGD & PGS

Preimplantation Genetic Testing for Aneuploidies (PGT-A) is a genetic test that examines embryos for chromosomal abnormalities before implantation. Aneuploidy refers to an abnormal number of chromosomes, which can lead to genetic disorders. PGT-A ensures that embryos have the correct number of chromosomes, increasing the chances of a successful pregnancy and reducing the risk of miscarriage.

Who Should Consider PGT-A?

PGT-A is beneficial for:
Individuals who have experienced multiple failed IVF cycles.
Those with a history of recurrent miscarriages.
Couples with a family history of genetic disorders.
Women over the age of 35.
Individuals who have had previous pregnancies with chromosomal abnormalities.
Consult with your fertility doctor to determine if PGT-A is right for you.

Benefits of PGT-A

Increased IVF Success Rates: Helps select the healthiest embryos for implantation.
Reduced Risk of Miscarriage: Minimizes the chance of implanting embryos with chromosomal abnormalities.
Enhanced Embryo Selection: Identifies the best embryos, reducing the need to transfer multiple embryos.
Prevention of Genetic Disorders: Lowers the risk of passing on genetic disorders to the child.

PGT-A Procedure

Embryo Biopsy: Performed at the blastocyst stage (day 5 or 6 after fertilization).
Chromosomal Analysis: Biopsied cells are analyzed for chromosomal anomalies using advanced technology.
Embryo Transfer: Only embryos with the correct number of chromosomes are selected for transfer.

Steps in PGT-A

Medical Diagnosis: Consultation with fertility doctors to discuss the need for PGT-A based on your medical history.
Genetic Counselling: Detailed discussion on genetic risks and the implications of PGT-A.
Preparation for PGT-A: Blood samples from both partners are taken to prepare for the PGT workup, followed by the IVF cycle.